Why the study?
Does spinal cord stimulation reduce the incidence of arrhythmia, heart failure, and sudden cardiac death after myocardial ischemia/infarction?
Does spinal cord stimulation reduce the incidence of arrhythmia, heart failure, and sudden cardiac death after myocardial ischemia/infarction?
Answers are grounded in this paper and cite their sources.
Spinal cord stimulation may offer a therapeutic strategy to reduce arrhythmias and heart failure following myocardial ischemia/infarction by modulating autonomic tone and inhibiting cardiac remodeling.
Fatal arrhythmias, heart failure, and sudden cardiac death after myocardial ischemia/infarction are serious threats to human health. In recent years, studies have shown that spinal cord stimulation (SCS) can balance autonomic activity, inhibit myocardial structural remodeling, improve blood flow to ischemic myocardium, effectively reduce the incidence of arrhythmia, heart failure and sudden cardiac death after myocardial ischemia/infarction, but its specific mechanism has not yet been fully elucidated. The effect of SCS on cardiac function may be achieved by inhibiting neural remodeling, or by ameliorating structural remodeling and electrical remodeling. This article reviews the progress on the role and mechanism of SCS in myocardial ischemia/infarction.
No takes yet. Share an insight, caveat, or question.
He et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: